was bacterially expressed and purified on glutathione agarose, and the purified protein was eluted with glutathione and quantified. Eluted GST-cGASP was added to the MBP-DOR slurry just before addition of in vitro-translated full-length GASP probe. 
Takeshi Watanabe, 5 James F. Zachary, 2 Halina Offner, 6 Elizabeth P. Blankenhorn, 7 Cory Teuscher 3 *
Bphs controls Bordetella pertussis toxin (PTX )-induced vasoactive amine sensitization elicited by histamine ( VAASH) and has an established role in autoimmunity. We report that congenic mapping links Bphs to the histamine H 1 receptor gene (Hrh1/H1R) and that H1R differs at three amino acid residues in VAASH-susceptible and -resistant mice. Hrh1 -/-mice are protected from VAASH, which can be restored by genetic complementation with a susceptible Bphs/Hrh1 allele, and experimental allergic encephalomyelitis and autoimmune orchitis due to immune deviation. Thus, natural alleles of Hrh1 control both the autoimmune T cell and vascular responses regulated by histamine after PTX sensitization.
PTX is a major virulence factor of B. pertussis, the causative agent of Whooping Cough (1) . The holotoxin is a hexameric protein that conforms to the ␣␤ model of bacterial exotoxins (2) . The ␣ subunit is an adenosine diphosphate (ADP)-ribosyl transferase, which affects signal transduction by ribosylation of the ␣ subunit of trimeric G i proteins, whereas the ␤ oligomer binds cell surface receptors on a variety of mammalian cells (2, 3) . PTX, when administered in vivo, elicits a range of responses including disruption of glucose regulation, leukocytosis, adjuvant activity, increased vascular permeability associated with alteration of blood-tissue barrier functions, and sensitization to vasoactive amines (VAAS) (4, 5) . The latter two phenotypes are the result of PTX-induced changes in vascular endothelial cells. Inbred strains of mice differ in susceptibility to vasoactive amine challenge after PTX sensitization in that genetically susceptible strains die from hypotensive and hypovolemic shock, whereas resistant strains do not (4) . Additionally, the genetic control of susceptibility to lethal shock is vasoactive amine specific (4) and is mediated through a variety of mechanisms (6) (7) (8) (9) .
Hypersensitivity to histamine after PTX sensitization (VAASH) is controlled by an autosomal dominant locus known as Bphs (10) . Bphs was one of the first nonmajor histocompatibility complex-linked genes shown to be involved in susceptibility to multiple autoimmune diseases (10) . Previously, we mapped Bphs on mouse chromosome 6 using backcross populations generated with susceptible SJL/J and resistant C3H/ HeJ and CBA/J mice (10) . As the first step in positionally cloning Bphs, we generated a panel of recombinant, interval-specific congenic lines using marker-assisted selection to introgress the SJL/J Bphs allele (Bphs s ) onto the C3H/HeJ background (11) . These lines were tested for susceptibility to VAASH (Table 1). The results establish that Bphs resides within an interval Յ1 cM between D6Mit107 and D6Mit41, encompassing Hrh1. Additionally, homozygous and heterozygous C3H.SJL-Bphs line D mice are as sensitive to VAASH as SJL/J, over a dose range of 6.25 to 100 mg/kg (table S1). This is consistent with dominance and a lack of gene dosage effect at this locus (10) .
It is known that the histamine H 1 receptor antagonist mepyramine can block VAASH in rats (12) , and, because Hrh1 resides within the interval encoding Bphs, Hrh1 was a candidate gene for Bphs. Therefore, we cloned and sequenced the Hrh1 alleles from cDNA samples of 14 inbred strains of mice (table  S2) . With the exception of C3H/HeJ and CBA/J, all mouse strains are susceptible to VAASH. Hrh1 sequences from susceptible and resistant mouse strains exhibited multiple, single nucleotide polymorphisms. However, among these polymorphisms, only three led to distinct and concordant amino acid changes in the predicted sequence (L263P, M313V, and S331P), all of which distinguish C3H/HeJ and CBA/J from all other strains of mice ( fig. S1 ).
The identity of Hrh1 as Bphs was further verified using C57BL/6-Hrh1 -/- (13) (table S3) . Taken together, our results establish that Hrh1 is Bphs and suggest that one or a combination of the critical amino acids at positions 263, 313, and 331 in the third intracellular loop, associated with signal transduction (15) , underlies susceptibility and resistance to VAASH.
Next, we assessed the role of Bphs/Hrh1 in autoimmune disease. In the first study, (C3H/HeJ ϫ SJL/J) ϫ C3H/HeJ mice were phenotyped for susceptibility to experimental allergic encephalomyelitis (EAE), experimental allergic orchitis (EAO), and VAASH (11) . Linkage of VAASH to EAE and EAO susceptibility was detected ( 2 ϭ 6.42; P ϭ 0.01 for EAE and 2 ϭ 5.60; P ϭ 0.02 for EAO). When the populations were combined, the significance of the linkage was greater indicating that Bphs/Hrh1 alleles behaved in a similar fashion genetically in both autoimmune diseases ( 2 ϭ 11.49; P ϭ 0.00007). These results confirm that Bphs is linked to susceptibility to EAE and EAO and are consistent with previous results indicating that Bphs is one of several autoimmune disease modifying genes shared between these two models (16) .
Because PTX sensitization at the time of immunization induces CD4 ϩ T cells that are responsible for mediating enhanced and protracted delayed-type hypersensitivity responses (17) by producing extremely high levels of ␥-interferon (IFN␥) after antigenic stimulation (18, 19) , and because histamine has recently been shown to regulate immune deviation through differential expression of histamine H 1 and H 2 receptors (20), we directly assessed the role of Hrh1 in susceptibility to both myelin oligodendrocyte glycoprotein (MOG) peptide 35-55 (MOG 35-55)-induced EAE and testis antigeninduced EAO. With respect to MOG-induced EAE, the day of disease onset was delayed, and the severity of clinical signs markedly reduced in C57BL/6-Hrh1 -/-compared with C57BL/6 wild-type mice (Fig. 1A) . Similar results were seen with autoimmune orchitis (table S4) . These results again indicate that Hrh1 fulfills the role of Bphs in both EAE and EAO.
The examination of a variety of T cell parameters showed that proliferation of draining lymph node (DLN) cells did not differ between wild-type and Hrh1 -/-mice immunized with the MOG 35-55 (Fig. 1B) . In contrast, cytokine production by splenocytes differed considerably. IFN␥ production was markedly decreased (Fig. 2A) , whereas interleukin-4 (IL-4) production was increased in Hrh1 -/-mice compared with wild-type mice (Fig. 2B) . Tumor necrosis factor-␣ (TNF␣), IL-2, and IL-5 cytokines were measured with no difference in cytokine production detected between the two groups ( fig. S2) (21) . With respect to antigen-specific proliferation, our results differ from the earlier report by Banu and Watanabe. However, this difference is readily attributable to the different immunization protocols used. Subsequently, it was shown that histamine acting through H1R enhances T helper-1 cell ( T H 1) responses, whereas both T H 1 and T H 2 responses are suppressed by signaling through H2R. H1R is more abundant than H2R on T H 1 cells. Thus the disruption of Hrh1 leads to immune deviation of T cell responses characterized by the suppression of IFN␥ production and an up-regulation in the production of T H 2-related cytokines (20) . These findings are consistent with the role of Bphs/Hrh1 in MOGinduced EAE, in which the T cell response in Hrh1 -/-mice was strongly T H 2 biased and associated with less severe disease.
We have identified Hrh1 as the general autoimmune disease susceptibility locus Bphs and have presumably delineated the critical amino acid residues that underlie the coupling of H1R to the Gq/11-second messenger pathway that mediates cell-specific responses (15, 21) . To date, H1R has not been modeled with respect to its coupling to second messenger pathways. However, the cytoplasmic amino acids that are phosphorylated and are involved in H1R desensitization by phorbol esters have been identified, and they are distinct from the polymorphic residues identified in this study (22) . In endothelial cells, H1R-mediated signaling responses include the ability of histamine to directly cause vasodilation and increased vascular permeability (5) and the release from Weibel Palade (WP) bodies (7 ) of stored vasoactive factors (IL-8, von Willebrand Factor, P-selectin, endothelin, and CD63) whose synthesis is induced by inflammatory stimuli such as PTX (8, 9) . The role of histamine as a secretagogue for the release of stored vasoactive factors from WP bodies (7-9) is consistent with the fact that VAASH persists upward of 60 days (4 ). Histamine and histamine-releasing agents also have dramatic effects on the blood-testis (23) and blood-brain barriers (24 ) , and, in both EAO and EAE, tissue levels of histamine correlate with the onset of disease (25, 26 ) . It has long been known (27, 28) , and recently reaffirmed (29, 30) , that H1R selective antagonists significantly inhibit susceptibility to EAE, and we have observed similar results in EAO (table S4) . In T cells, signaling through H1R results in Ca 2ϩ mobilization causing the translocation of nuclear factor of activated T cells (NFAT) to the nucleus and activation of the IL-2 gene (21) and, via an unknown mechanism, immune deviation of T cells (20) . Our results demonstrate how the characterization of a monogenic, qualitative intermediate phenotype can result in the identification of a gene that mimics a quantitative trait locus due to its activity in multiple cell types. The identification of Hrh1 as Bphs also represents an example of an autoimmune disease susceptibility gene that func- Table 2 . Assessment of VAASH in C57BL/6-Hrh1 -/-and C57BL/6-Hrh2 -/-mice and F 1 progeny between C57BL/6-Hrh1 -/-mice and Bphs s/s and Bphs h/h strains. Mice were sensitized with 400 ng purified PTX (List Biological Laboratories, Inc.) by i.v. injection on day 0. On day 3, mice were challenged with histamine (mg dry weight free base) by i.v. injection, and deaths were recorded at 30 min post challenge. The results are expressed as the number of animals dead over the number of animals studied. tions at critical checkpoints during both the induction and effector phases of two different induced autoimmune diseases. To screen for mutants with enhanced susceptibility to pathogens (Esp), we exposed mutagenized F 2 generation L4 larval stage nematodes to Pseudomonas aeruginosa strain PA14 under slow killing assay conditions, which involve an infection-like process requiring live pathogenic bacteria (2) . The population of worms was then screened after a period of 16 to 30 hours for dead animals (wild-type animals typically began to die at approximately 34 hours). Under these conditions, hermaphrodite animals died as gravid adults; thus, putative mutants were recovered by transferring individual dead worms containing their brood to plates seeded with the standard laboratory nematode food source, Escherichia coli OP50, whereupon the progeny were recovered. Potential mutants were rescreened by a comparative evaluation of survival on OP50 and pathogen PA14.
We screened an estimated 14,000 haploid genomes and selected for further study two of an initially isolated 10 mutants, esp-2(ag1) and esp- 8(ag3) , that had similar and the most penetrant Esp phenotypes. When animals were exposed to PA14 under standard assay conditions, 100% of esp-2 animals, 90% of esp-8, and 0% of wild-type animals were killed by 31 hours (Fig. 1A) . To monitor the course of infection in the esp-2 and esp-8 mutant animals, worms were fed green fluorescent protein (GFP)-labeled PA14 (2). Accumulation of PA14 in the intestine (detected as early as 6 hours in esp-2 and esp-8 animals after exposure to GFP-labeled PA14) was correlated with the kinetics of killing. After 20 hours on GFP-labeled PA14, esp-2 and esp-8 animals had an overwhelming accumulation of PA14 in the anterior portion of their intestines, whereas wild-type animals showed minimal accumulation of GFP-labeled PA14 (Fig. 1D) . Of note, the enhanced susceptibility of esp-2 and esp-8 mutant animals was not specific to the Gram-negative pathogen, P. aeruginosa, because the mutants were also hypersusceptible to the Gram-positive pathogen Enterococcus faecalis (Fig. 1C) , which also kills C. elegans (3) .
An implicit concern with the isolation of C. elegans mutants with enhanced susceptibility to pathogens is that many loss-of-function mutations might compromise the overall health of the worm, resulting in a secondary increased sensitivity to pathogens. In fact,
